280 results on '"Rubio-Aliaga, Isabel"'
Search Results
2. Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation
3. Phosphate intake, hyperphosphatemia, and kidney function
4. The calcium-sensing receptor has only a parathyroid hormone-dependent role in the acute response of renal phosphate transporters to phosphate intake
5. The calcium-sensing receptor has only a parathyroid hormone-dependent role in the acute response of renal phosphate transporters to phosphate intake.
6. Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation
7. Marked alterations in the structure, dynamics and maturation of growth plate likely explain growth retardation and bone deformities of young Hyp mice
8. Renal phosphate handling and inherited disorders of phosphate reabsorption: an update
9. Profilierungstechniken in der Ernährungs- und Lebensmittelforschung
10. Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients.
11. Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia.
12. Proteomics in the Systems-Level Study of the Metabolic Syndrome
13. Loss of function mutation of the Slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in the liver, brain, and kidney
14. Chronic High Phosphate Intake in Mice Affects Macronutrient Utilization and Body Composition
15. Systemic Jak1 activation causes extrarenal calcitriol production and skeletal alterations provoking stunted growth
16. Jak1/Stat3 Activation Alters Phosphate Metabolism Independently of Sex and Extracellular Phosphate Levels
17. Systemic Jak1 activation causes extrarenal calcitriol production and skeletal alterations provoking stunted growth
18. Is fibroblast growth factor 23 the main culprit for cardiovascular disease in chronic kidney disease?
19. New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis
20. New metabolic interdependencies revealed by plasma metabolite profiling after two dietary challenges
21. Metabolomics of prolonged fasting in humans reveals new catabolic markers
22. Profilierungstechniken in der Ernährungs- und Lebensmittelforschung
23. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH
24. Genetic diseases of renal phosphate handling
25. Stimulation of electrogenic intestinal dipeptide transport by the glucocorticoid dexamethasone
26. Genome-wide search for genes that modulate inflammatory arthritis caused by Ali18 mutation in mice
27. A chronic high phosphate intake in mice is detrimental for bone health without major renal alterations
28. Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage
29. Phenotype analysis of mice deficient in the peptide transporter PEPT2 in response to alterations in dietary protein intake
30. A genetic screen for modifiers of the Delta1-dependent Notch signaling function in the mouse
31. Proteomics in the Systems-Level Study of the Metabolic Syndrome
32. An update on renal peptide transporters
33. Mammalian peptide transporters as targets for drug delivery
34. [H.sup.+]-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1
35. Model organisms in molecular nutrition research
36. Mechanisms of weight maintenance under high- and low-protein, low-glycaemic index diets
37. Nutrigenomics in human intervention studies: Current status, lessons learned and future perspectives
38. Phosphate and Kidney Healthy Aging
39. PEPT-1, Peptide Transporter 1
40. PEPT-2, Peptide Transporter 2
41. Altered signalling from germline to intestine pushes daf-2;pept-1 Caenorhabditis elegans into extreme longevity
42. MAPK inhibition and growth hormone: a promising therapy in XLH
43. Erratum to: New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis
44. MAPK inhibition and growth hormone: a promising therapy in XLH
45. Fibroblast growth factor 23 in chronic kidney disease: what is its role in cardiovascular disease?
46. 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting
47. Amino acid handling in the organism, lessons from mouse and human studies
48. The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
49. NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosis
50. Renal phosphate handling and inherited disorders of phosphate reabsorption: an update
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.